Literature DB >> 11481303

A comparison of culture and PCR to determine the prevalence of ampicillin-resistant bacteria in the faecal flora of general practice patients.

J Heritage1, N Ransome, P A Chambers, M H Wilcox.   

Abstract

Of 95 faecal specimens containing bacterial DNA amplified by PCR, 24% contained cultivable bacteria that were resistant to high-level ampicillin. When these samples were examined by PCR using primers to amplify the bla(TEM) gene, the number of positive samples identified increased significantly to 49 (52%). These results indicate that ampicillin resistance is common in the study population. Furthermore, the bla(TEM) gene is more common than indicated by the recovery of resistant bacteria in culture. This points to potential anomalies in the assessment of the prevalence of resistance when relying on recovery of resistant bacteria by culture.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11481303     DOI: 10.1093/jac/48.2.287

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  4 in total

1.  P1A recombinant beta-lactamase prevents emergence of antimicrobial resistance in gut microflora of healthy subjects during intravenous administration of ampicillin.

Authors:  Ann-Mari Tarkkanen; Tuula Heinonen; Rain Jõgi; Silja Mentula; Michel E van der Rest; Curtis J Donskey; Tuomas Kemppainen; Konstantin Gurbanov; Carl Erik Nord
Journal:  Antimicrob Agents Chemother       Date:  2009-03-23       Impact factor: 5.191

2.  Low Prevalence of Aeromonas hydrophilain Infectious Diarrhea Samples of Pediatric Patients in Arak, Iran.

Authors:  Elnaz Abbasi; Behzad Khansari-Nejad; Hamid Abtahi; Majid Akbari; Ehsanollah Ghaznavi-Rad
Journal:  Rep Biochem Mol Biol       Date:  2016-10

3.  Impact of three ampicillin dosage regimens on selection of ampicillin resistance in Enterobacteriaceae and excretion of blaTEM genes in swine feces.

Authors:  D Bibbal; V Dupouy; J P Ferré; P L Toutain; O Fayet; M F Prère; A Bousquet-Mélou
Journal:  Appl Environ Microbiol       Date:  2007-06-08       Impact factor: 4.792

4.  Orally administered targeted recombinant Beta-lactamase prevents ampicillin-induced selective pressure on the gut microbiota: a novel approach to reducing antimicrobial resistance.

Authors:  Jaana Harmoinen; Silja Mentula; Matti Heikkilä; Michel van der Rest; Päivi J Rajala-Schultz; Curtis J Donskey; Rafael Frias; Pertti Koski; Nina Wickstrand; Hannele Jousimies-Somer; Elias Westermarck; Kai Lindevall
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.